Task: Answer Verification
Input (English): Question: Does combined corticosteroid and cyclophosphamide therapy alter survival in idiopathic pulmonary fibrosis?
Answer: Our data suggest that combined corticosteroid and cyclophosphamide therapy has no impact on survival in patients with IPF. This finding supports the evolving concept that chronic inflammation plays a minimal role in the progression of IPF and reinforces the importance of careful consideration of the risks and benefits of such therapies prior to their institution.
Output (English): no